Mark Bachleda
Keine laufenden Positionen mehr
Vermögen: 2 365 $ am 31.05.2024
Karriereverlauf von Mark Bachleda
Ehemalige bekannte Positionen von Mark Bachleda
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | 12.10.2021 | 09.08.2023 |
| JUNO THERAPEUTICS INC | Vertrieb & Marketing | - | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Ausbildung von Mark Bachleda
| University of Illinois | Doctorate Degree |
| University of California, Berkeley | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Mark Bachleda
- Erfahrung
